Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting133%
unknown133%
not_yet_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Comparison of Milrinone and Epinephrine on TAPSE

NCT07144267
recruitingphase_2

Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

NCT04282629
unknown

Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery

NCT04153383

Clinical Trials (3)

Showing 3 of 3 trials
NCT07144267Not Applicable

Comparison of Milrinone and Epinephrine on TAPSE

Not Yet Recruiting
NCT04282629Phase 2

Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

Recruiting
NCT04153383

Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3